Literature DB >> 6203454

NIH conference. Aldose reductase and complications of diabetes.

D G Cogan, J H Kinoshita, P F Kador, G Robison, M B Datilis, L M Cobo, C Kupfer.   

Abstract

Tissues of the eye affected by diabetes are the lens, cornea, and retina. The lens becomes cataractous through osmotic swelling of its cortical fibers. Sorbitol, formed in the presence of aldose reductase, accumulates in the lens during hyperglycemia. Dulcitol similarly accumulates in the presence of galactosemia. Cataractogenesis in both cases can be prevented by inhibitors of aldose reductase. The efficacy of synthetic inhibitors differs in various tissues and species, but they react with aldose reductase at a common structural site. The most promising inhibitor is sorbinil . Diabetic retinopathy is similarly related to sorbitol accumulation and may be prevented or reversed by inhibition of aldose reductase. Healing of corneal wounds in diabetes is facilitated by enzyme inhibition. Retinal vasculopathy of diabetes is due to selective loss of the intramural pericytes that normally form structural elements in the retinal capillary walls. The vulnerability of these cells is due to their aldose reductase content. Whether inhibition of aldose reductase will prevent retinopathy is being tested in a randomized trial conducted by the National Eye Institute.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6203454     DOI: 10.7326/0003-4819-101-1-82

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  27 in total

1.  Freeze-fracture observations on normal and abnormal human perineurial tight junctions: alterations in diabetic polyneuropathy.

Authors:  N G Beamish; C Stolinski; P K Thomas; R H King
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 2.  Understanding the role of aldose reductase in ocular inflammation.

Authors:  U C S Yadav; S K Srivastava; K V Ramana
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

3.  The polyol pathway in retinal microangiopathy.

Authors:  W G Robison; J H Kinoshita; P F Kador
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Response of rat retinal capillary pericytes and endothelial cells to glucose.

Authors:  Jun Makita; Ken-ichi Hosoya; Peng Zhang; Peter F Kador
Journal:  J Ocul Pharmacol Ther       Date:  2010-11-20       Impact factor: 2.671

5.  Hyperglycemia and the pathogenesis of diabetic retinopathy.

Authors:  G L King
Journal:  J Gen Intern Med       Date:  1986 Mar-Apr       Impact factor: 5.128

6.  A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients.

Authors:  M Nakahara; K Miyata; S Otani; T Miyai; R Nejima; S Yamagami; S Amano
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

7.  Chronic exposure to high glucose decreases myo-inositol in cultured cerebral microvascular pericytes but not in endothelium.

Authors:  I Sussman; M P Carson; V Schultz; X P Wu; A L McCall; N B Ruderman; K Tornheim
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

8.  Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235.

Authors:  H Fujishima; K Tsubota
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

Review 9.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

10.  Effect of cyclospasmol on early diabetic retinopathy.

Authors:  M C Mota; E Leite; M A Ruas; H L Verjans; C B Blakemore; J G Cunha-Vaz
Journal:  Int Ophthalmol       Date:  1987-02       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.